EUVIMEDEUVIMED entdecken
Crossref

Targeted and Untargeted GC–MS Metabolomics Coupled With Multivariate Chemometric Modeling Reveals Pioglitazone's Impact on Diabetic Rats

Maram H Abduljabbar, Duaa Abdullah Bafail, Reem M Alnemari, Ahmed Serag iD, Atiah H Almalki

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202502006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Maram H Abduljabbar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, Taif, Saudi Arabia. Hauptthemen laut MEDLINE: Pioglitazone, Metabolomics, Diabetes Mellitus, Experimental, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Taif University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia and alterations in metabolic pathways. Herein, gas chromatography–mass spectrometry (GC–MS) metabolomics was employed to investigate the changes in serum metabolites of streptozotocin‐induced diabetic rats in response to pioglitazone treatment. Both untargeted and targeted analyses were conducted to identify and quantify the key metabolic perturbations. Multivariate analysis modeling such as principal component analysis (PCA), partial least squares‐discriminant analysis (PLS‐DA), and orthogonal projections to latent structures DA (OPLS‐DA) revealed significant differences in the metabolic profiles among the diabetic, pioglitazone‐treated, and control groups. A panel of 15 differentially altered metabolites was identified, of which a targeted quantification was performed of 6 key metabolites that were significantly modulated by pioglitazone treatment. These metabolites include two branched‐chain amino acids ( l ‐isoleucine, l ‐valine), two organic acids (lactic, beta‐hydroxybutyric), and two fatty acids (palmitic, stearic). Interestingly, pathway analysis revealed the inability of pioglitazone to restore the levels of some metabolites, suggesting possible persistent metabolic alterations in diabetes even after treatment. This metabolic signature offers significant potential for clinical translation, serving as a biomarker panel for monitoring diabetes progression and therapeutic efficacy. Such comprehensive GC–MS metabolomics platform provides a robust analytical framework for accelerating diabetes drug discovery, enabling precise therapeutic monitoring, and facilitating personalized medicine approaches in diabetes management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PioglitazoneMetabolomicsDiabetes Mellitus, ExperimentalHypoglycemic AgentsAnimalsGas Chromatography-Mass SpectrometryRatsMaleMultivariate AnalysisPrincipal Component AnalysisRats, Sprague-DawleyDiscriminant AnalysisStreptozocinChemometrics

Stichwörter der Autor:innen

biomarkersmetabolomicsmultivariate analysis streptozotocinthiazolidinediones

Substanzen

PioglitazoneHypoglycemic AgentsStreptozocin

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, Taif, Saudi Arabia.
  • Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia.
  • Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt.
  • Addiction and Neuroscience Research Unit, Health Science Campus, Taif University, Taif, Saudi Arabia.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, Taif, Saudi Arabia.

ORCID-Profile: Ahmed Serag

Förderung

  • Taif University

Zitieren

APA

Abduljabbar, M. H., Bafail, D. A., Alnemari, R. M., Serag, A., & Almalki, A. H. (2025). Targeted and Untargeted GC–MS Metabolomics Coupled With Multivariate Chemometric Modeling Reveals Pioglitazone's Impact on Diabetic Rats. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202502006

Vancouver

Abduljabbar MH, Bafail DA, Alnemari RM, Serag A, Almalki AH. Targeted and Untargeted GC–MS Metabolomics Coupled With Multivariate Chemometric Modeling Reveals Pioglitazone's Impact on Diabetic Rats. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202502006

BibTeX
@article{Abduljabbar2025,
  author = {Abduljabbar, Maram H and Bafail, Duaa Abdullah and Alnemari, Reem M and Serag, Ahmed and Almalki, Atiah H},
  title = {Targeted and Untargeted GC–MS Metabolomics Coupled With Multivariate Chemometric Modeling Reveals Pioglitazone's Impact on Diabetic Rats},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202502006}
}
Kostenlos starten →